November 5, 2020

Human Frontier Science Program Recognizes Dewpoint Founder Tony Hyman for His Pioneering Work on Biomolecular Condensates

Dewpoint Therapeutics congratulates Scientific founder Anthony Hyman on receiving the 2021 HFSP Nakasone Award from The Human Frontier Science Program (HFSP). The award was granted to Tony Hyman and Clifford Brangwynne for their discovery of a new state of biological matter, phase-separated macromolecule condensates, that play an important role in cell organisation, gene regulation, signalling and pathology.

The HFSP Nakasone Award was established to honour scientists who have made key breakthroughs in fields at the forefront of the life sciences. It recognizes the vision of Japan’s former Prime Minister Nakasone in the creation of the international science funding organisation.


Media Contact

Investor Contact

Michael Fenn, PH.D.
Head of External Innovation
Dewpoint Therapeutics
Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science